Uvax Bio
0 followers
‌
Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology developed by Professor Jiang Zhu of Scripps Research to develop and commercialize B-cell focused, rap... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Ji Li
Collapse
Jiang Zhu
Co-founder And CSO
Kevin O'neill
Senior Vice President Of Corporate Strategy
Ke Li
Vice President Of Vaccine Development And Technical Operations
Pedro Garbes
Vice President, Global Medical Lead
Deven Sandhu
Managing Director (uvaxbio, 🇨🇦); VP CMC Regulatory Compliance ( Uvaxbio)
